Giulio Draetta, Chief Scientific Officer at The University of Texas M.D. Anderson Cancer Center, shared on Twitter:
“Tremendously proud of Tina Cascone for her presentation at the 2023 ESMO meeting presidential session on the impact of neoadjuvant NIVO/chemo in respectable NSCLC.”
Source: Giulio Draetta/Twitter